Cash Flow from Operating Activities: A company's cash flows from operations.
Crescent Biopharma, Inc. (CBIO) had Cash Flow from Operating Activities of $-5.11M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.34M |
|
-- |
|
-- |
|
$2.40M |
|
$-2.40M |
|
$0.06M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.40M |
|
$-2.40M |
|
0.65M |
|
0.65M |
|
$-4.00 |
|
$-4.00 |
|
| Balance Sheet Financials | |
$5.99M |
|
-- |
|
-- |
|
$5.99M |
|
$2.62M |
|
-- |
|
-- |
|
$2.62M |
|
$3.38M |
|
$3.38M |
|
$3.38M |
|
0.65M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.11M |
$0.00M |
|
$0.00M |
|
$10.72M |
|
$5.61M |
|
$-5.11M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.44% |
|
-69.44% |
|
-39.11% |
|
-69.44% |
|
$5.23 |
|
$-7.91 |
|
$-7.91 |
|